Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avigad S., Barel D., Blau O., Malka A., Zoldan M., Mor C., Fogel M., Cohen I. J., Stark B., Goshen Y. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene. 1997 Apr 3;14(13):1541–1545. doi: 10.1038/sj.onc.1200990. [DOI] [PubMed] [Google Scholar]
- Campbell I. G., Eccles D. M., Dunn B., Davis M., Leake V. p53 polymorphism in ovarian and breast cancer. Lancet. 1996 Feb 10;347(8998):393–394. doi: 10.1016/s0140-6736(96)90569-3. [DOI] [PubMed] [Google Scholar]
- Lancaster J. M., Brownlee H. A., Wiseman R. W., Taylor J. p53 polymorphism in ovarian and bladder cancer. Lancet. 1995 Jul 15;346(8968):182–182. doi: 10.1016/s0140-6736(95)91239-8. [DOI] [PubMed] [Google Scholar]
- Peller S., Kopilova Y., Slutzki S., Halevy A., Kvitko K., Rotter V. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol. 1995 Dec;14(12):983–990. doi: 10.1089/dna.1995.14.983. [DOI] [PubMed] [Google Scholar]
- Runnebaum I. B., Tong X. W., König R., Zhao H., Körner K., Atkinson E. N., Kreienberg R., Kieback D. G., Hong Z [corrected to Zhao H. ]. p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet. 1995 Apr 15;345(8955):994–994. doi: 10.1016/s0140-6736(95)90745-9. [DOI] [PubMed] [Google Scholar]